Viewing Study NCT04809220


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:12 AM
Study NCT ID: NCT04809220
Status: COMPLETED
Last Update Posted: 2024-05-22
First Post: 2021-03-19
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-04-13
Start Date Type: ACTUAL
Primary Completion Date: 2022-10-01
Primary Completion Date Type: ACTUAL
Completion Date: 2023-04-26
Completion Date Type: ACTUAL
First Submit Date: 2021-03-19
First Submit QC Date: None
Study First Post Date: 2021-03-22
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-08-24
Results First Submit QC Date: None
Results First Post Date: 2023-09-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-04-25
Last Update Post Date: 2024-05-22
Last Update Post Date Type: ACTUAL